Author
J. E. Guikema
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2019-2023 · peak 1/yrCo-Author Collaboration Network
10 top collaborators · 20 mutual co-author links4 papers
Recent·Most cited
Convergent Evolution and B-Cell Recirculation in Germinal Centers in a Human Lymph Node
A. Pelissier, M. Stratigopoulou, N. Donner, E. Dimitriadis, R. J. Bende, J. E. Guikema, M. R. Martinez, C. J. M. van Noesel
The paper analyzes B-cell clonal diversity and evolution in human germinal centers using LCM and Rep-seq, finding convergent evolution and shared antigen responses across GCs.
bioRxiv · Nov 9, 2022Evolutionary Biology
DNA polymerase β prevents AID-instigated mutagenic non-canonical mismatch DNA repair
M. Bahjat, M. Stratigopoulou, B. Pilzecker, T. P. van Dam, S. Mobach, R. J. Bende, C. J. van Noesel, H. E. Jacobs, J. E. Guikema
The paper shows that DNA polymerase β degradation in GC B cells leads to mutagenic non-canonical mismatch repair, promoting A:T mutations during somatic hypermutation.
bioRxiv · Jan 30, 2020 · PreprintImmunology
Targeting AKT elicits tumor suppressive functions of FOXO transcription factors and GSK3 kinase in Multiple Myeloma
T. A. Bloedjes, G. de Wilde, C. Maas, E. E. Eldering, R. J. Bende, C. J. van Noesel, S. T. Pals, M. Spaargaren, J. E. Guikema
This study shows that AKT inhibition in multiple myeloma activates FOXO and GSK3, leading to MCL1 reduction and cell death, suggesting potential for combination therapies.
bioRxiv · Oct 24, 2019Cancer Biology